Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.16B |
| 2 |
Bank of America
BAC
|
+$855M |
| 3 |
Comcast
CMCSA
|
+$620M |
| 4 |
Amazon
AMZN
|
+$505M |
| 5 |
Micron Technology
MU
|
+$486M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Goldman Sachs
GS
|
+$441M |
| 2 |
Palo Alto Networks
PANW
|
+$300M |
| 3 |
Verizon
VZ
|
+$286M |
| 4 |
Fidelity National Information Services
FIS
|
+$285M |
| 5 |
Stanley Black & Decker
SWK
|
+$244M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 6.22% |
| 2 | Financials | 6.16% |
| 3 | Industrials | 5.09% |
| 4 | Consumer Discretionary | 4.89% |
| 5 | Healthcare | 4.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
WCG
1826
PUT
DELISTED
Wellcare Health Plans, Inc.
WCG
| $8.06M | ﹤0.01% |
40,100
+30,200
| +305% | +$5.85M |
|
1827
Gen Digital
GEN
$17B
| $8.04M | ﹤0.01% |
286,372
+113,945
| +66% | +$3.41M |
|
1828
PUT
D.R. Horton
DHI
$41.6B
| $8.02M | ﹤0.01% |
157,100
+27,100
| +21% | +$1.26M |
|
1829
iShares MSCI United Kingdom ETF
EWU
$4.13B
| $8M | ﹤0.01% |
223,384
+134,901
| +152% | +$4.72M |
|
1830
PUT
Alnylam Pharmaceuticals
ALNY
$30.6B
| $7.99M | ﹤0.01% |
62,900
-29,400
| -32% | -$3.69M |
|
1831
PUT
HP
HPQ
$27.5B
| $7.98M | ﹤0.01% |
380,000
-100,000
| -21% | -$2.13M |
|
1832
CALL
Parker-Hannifin
PH
$133B
| $7.98M | ﹤0.01% |
40,000
-17,700
| -31% | -$3.29M |
|
|
TRUE
1833
DELISTED
TrueCar
TRUE
| $7.98M | ﹤0.01% |
712,668
-111,657
| -14% | -$1.47M |
|
1834
Pulse Biosciences
PLSE
$3.18B
| $7.97M | ﹤0.01% |
+337,906
| New | +$7.97M |
|
1835
Pilgrim's Pride
PPC
$6.64B
| $7.97M | ﹤0.01% |
256,632
-90,159
| -26% | -$2.94M |
|
1836
Sysco
SYY
$39.7B
| $7.97M | ﹤0.01% |
+131,246
| New | +$7.44M |
|
1837
CALL
Campbell Soup
CPB
$6.91B
| $7.97M | ﹤0.01% |
165,600
+65,900
| +66% | +$3.13M |
|
1838
Vanguard International Dividend Appreciation ETF
VIGI
$9.29B
| $7.96M | ﹤0.01% |
119,792
+65,630
| +121% | +$4.27M |
|
1839
PUT
Cognex
CGNX
$11B
| $7.95M | ﹤0.01% |
129,900
+76,300
| +142% | +$4.86M |
|
1840
Constellium
CSTM
$4.01B
| $7.95M | ﹤0.01% |
712,585
+630,078
| +764% | +$6.7M |
|
|
RSX
1841
CALL
DELISTED
VanEck Russia ETF
RSX
| $7.94M | ﹤0.01% |
374,200
-67,800
| -15% | -$1.49M |
|
|
FBM
1842
DELISTED
Foundation Building Materials, Inc. Common Stock
FBM
| $7.93M | ﹤0.01% |
535,911
-42,755
| -7% | -$605K |
|
1843
VanEck Semiconductor ETF
SMH
$72.4B
| $7.92M | ﹤0.01% |
161,958
+72,972
| +82% | +$3.64M |
|
|
ALOG
1844
DELISTED
Analogic Corp
ALOG
| $7.9M | ﹤0.01% |
94,288
-8,791
| -9% | -$727K |
|
1845
FMC
FMC
$1.27B
| $7.89M | ﹤0.01% |
96,066
+78,109
| +435% | +$6.28M |
|
|
TRTN
1846
DELISTED
Triton International Limited
TRTN
| $7.89M | ﹤0.01% |
210,574
-555,803
| -73% | -$21.4M |
|
1847
iShares Core S&P US Growth ETF
IUSG
$33.9B
| $7.88M | ﹤0.01% |
+146,631
| New | +$7.71M |
|
1848
Donaldson
DCI
$11.1B
| $7.88M | ﹤0.01% |
161,029
+107,274
| +200% | +$5.11M |
|
|
SEE
1849
CALL
DELISTED
Sealed Air
SEE
| $7.87M | ﹤0.01% |
159,700
+86,600
| +118% | +$3.98M |
|
1850
CALL
Upbound Group
UPBD
$1.14B
| $7.87M | ﹤0.01% |
708,700
+642,200
| +966% | +$7.03M |
|
Similar funds
Ken Griffin's Q4 2017 Portfolio in Review
As of Q4 2017, Ken Griffin held 8,908 positions worth $164B, up 26% from $130B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Ken Griffin deployed $21.1B of net new capital in Q4 2017, opening 1,440 new positions and adding to 3,569 existing holdings. Its largest new stake was Celgene Corp: 3,708,916 shares worth $387M.
By sector, the portfolio is most concentrated in Technology at 6.2% of assets, down from 7.2% a quarter earlier, followed by Financials and Industrials.
On the sell side, the largest reduction was Goldman Sachs, an estimated $441M trimmed.
- Ken Griffin's largest Q4 2017 buy was Celgene Corp: 3,708,916 shares worth $387M.
- Ken Griffin added most to State Street SPDR S&P 500 ETF Trust in Q4 2017, an estimated $1.16B increase.
- Ken Griffin's biggest Q4 2017 reduction was Goldman Sachs, cutting an estimated $441M.
- Ken Griffin fully exited CR Bard Inc. in Q4 2017, selling an estimated $209M.
- Ken Griffin's ten largest holdings make up 19% of its $164B portfolio in Q4 2017.
- Ken Griffin opened 1,440 new positions and closed 988 in Q4 2017.
- Ken Griffin's portfolio value rose 26% quarter-over-quarter to $164B.
Based on Citadel Advisors's 13F filing for Q4 2017, filed 9 Feb 2018.